gska markets throughout australia a range of pharmaceutical products including vaccines.
1 the applicant, csl limited ("csl"), seeks an interlocutory injunction to restrain the respondent, glaxosmithkline australia pty ltd ("gska"), from making certain representations concerning gardasil, a vaccine marketed by csl, and cervarix, a vaccine which gska hopes to market in australia in the near future.
2 csl carries on business developing, manufacturing, selling and supplying in australia plasma products, antivenoms and human vaccines.